client login

News Articles

<< Back

Needham, MA

June 27, 2008

Genzyme Science Center Earns LEED Gold Certification

Genzyme's new Science Center, an 180,000-square-foot facility at Genzyme Corporation's campus in Framingham, Mass., has earned the prestigious LEED Gold Certification from the U.S. Green Building Council (USGBC) becoming one of only 10 laboratories in the nation to achieve this high rating. The building was awarded 41 points by the USGBC to attain the LEED Gold Certification. Leadership in Energy and Environmental Design (LEED) is a nationally accepted benchmark for the design, construction and operation of high-performance sustainable buildings and is awarded by USGBC.

Researchers at the Science Center focus on a variety of medical areas including genetic diseases, cancer, immune diseases, kidney disease, cardiovascular disease, endocrinology and neurological disorders. In their work to develop new treatments, they utilize a range of technologies, such as proteins, antibodies, cell therapy and gene therapy.

As Genzyme's development manager, Murphy McManus led the efforts of the design and construction team. The Science Center was designed by ARC/Architectural Resources Cambridge, the engineer was Bard, Rao & Athanas Consulting Engineers Inc., and Bovis Lend Lease served as the general contractor for the project.

Murphy McManus provides comprehensive real estate services to healthcare, life science, and institutional/academic clients - from strategic planning and financial analysis to development management and project control to joint venture ownership and off balance sheet financing.